Phase 2/3 study of COVID-19 vaccine HDT-301
Latest Information Update: 26 Apr 2024
At a glance
- Drugs HDT-301 (Primary)
- Indications COVID 2019 infections
- Focus Registrational; Therapeutic Use
- Sponsors HDT Bio
- 24 Apr 2024 According to PharmaJet media release, The data from this trial published in Nature publication.
- 24 Apr 2024 Results published in the PharmaJet Media Release.
- 03 Sep 2021 New trial record